Please assess the completion status of the following clinical trial:

Trial Title: Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participation in the GHLIQUID-1517 trial~* Patients with SGA (small for gestational age) short stature that are still growing~Exclusion Criteria:~* Known or suspected allergy to study product(s) or related products~* Diabetes Mellitus~* Patients with malignant tumor(s)~* Pregnant or likely to get pregnant

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Norditropin® (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).